Skip to content

Randomized controlled clinical trial of Ermiao Pill combined with spinal nerve pulse radiofrequency therapy for herpes zoster neuralgia

Randomized controlled clinical trial of Ermiao Pill combined with spinal nerve pulse radiofrequency therapy for herpes zoster neuralgia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076459
Enrollment
Unknown
Registered
2023-10-09
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes neuralgia

Interventions

Group A:Ermiao pills were given orally, 6g twice a day, and spinal nerve pulse radiofrequency therapy was also given.
Group B:spinal nerve pulse radiofrequency therapy

Sponsors

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.In line with the Western medicine herpes zoster related pain diagnostic criteria, in line with the TCM constitution classification of damp-heat constitution diagnostic criteria; 2. Patients aged 18 years or older, male or female; 3. The patient received antiviral treatment before admission, and the pain control was not satisfactory, visual pain analog score (VAS) =4 points; 4.the lesion site is located in the thorax, waist, abdomen and limbs, no neurological dysfunction; 5. Able to understand and fill in various rating scales; 6. Sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, lung and renal insufficiency; 2. Patients with coagulation dysfunction; 3. Patients with cognitive dysfunction or poor coordination 4. Allergic constitution or history of drug sensitivity with similar structure; 5. Patients with experimental drug contraindications (respiratory depression, paralytic ileus, delirium); 6. History of drug use; 7. Patients with mental disorders or those judged by the researchers to be unfit to participate in this study.

Design outcomes

Primary

MeasureTime frame
visual analogue scale, VAS ;

Secondary

MeasureTime frame
ID Pain;Short form McGill pain questionnaire, SF-MPQ ;PGIC;Pittsburgh Sleep Quality Index, PSQI ;SF-36;

Countries

China

Contacts

Public ContactYing Huang

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School

huangy0808@nju.edu.cn+86 136 5517 5905

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026